There were cases of MTC reported in patients who took liraglutide (the active ingredient in Ozempic and Wegovy) after the drug was put on the market
Summary 5-Amino-1MQ is an orally active small molecule designed to support fat metabolism, energy utilization, and body composition by targeting cellular pathways involved in energy storage and expenditure
AOD9604 is administered either orally as a tablet or as an injection, with no scientifically validated evidence on dosing and usage being available
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
There are various different forms of cobalamin, some of which fulfil essential functions in our bodies